Celgene Corporation has acquired privately held Quanticel Pharmaceuticals, Inc., a biotechnology company focused on cancer drug discovery. Under the agreement terms, Celgene will acquire Quanticel for an upfront payment of $100 million in cash. Up to an additional $385 million in contingent payments may be achieved upon research, development, and regulatory advances related to Quanticel’s research and development platform. Through the agreement, Celgene will have full access to Quanticel’s...